CD79A and inflammatory bowel disease: Compared with healthy controls, both UC and CD patients exhibited significantly increased proportions of highly IgA-coated (IgA+), IgG-coated (IgG+), and IgM-coated (IgM+) bacteria (Fig. 1A–C), indicating enhanced immune targeting of gut microbiota in IBD.